These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 20170099

  • 21. Epiminocyclohepta[b]indole analogs as 5-HT6 antagonists.
    Henderson AJ, Guzzo PR, Ghosh A, Kaur J, Koo JM, Nacro K, Panduga S, Pathak R, Shimpukade B, Tan V, Xiang K, Wierschke JD, Isherwood ML.
    Bioorg Med Chem Lett; 2012 Feb 15; 22(4):1494-8. PubMed ID: 22290076
    [Abstract] [Full Text] [Related]

  • 22. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
    Hirst WD, Abrahamsen B, Blaney FE, Calver AR, Aloj L, Price GW, Medhurst AD.
    Mol Pharmacol; 2003 Dec 15; 64(6):1295-308. PubMed ID: 14645659
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT(6) antagonists.
    Liu KG, Robichaud AJ, Greenfield AA, Lo JR, Grosanu C, Mattes JF, Cai Y, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Comery TA.
    Bioorg Med Chem; 2011 Jan 01; 19(1):650-62. PubMed ID: 21093272
    [Abstract] [Full Text] [Related]

  • 25. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G, Butini S, Fattorusso C, Catalanotti B, Gemma S, Nacci V, Morelli E, Cagnotto A, Mereghetti I, Mennini T, Carli M, Minetti P, Di Cesare MA, Mastroianni D, Scafetta N, Galletti B, Stasi MA, Castorina M, Pacifici L, Vertechy M, Di Serio S, Ghirardi O, Tinti O, Carminati P.
    J Med Chem; 2004 Jan 01; 47(1):143-57. PubMed ID: 14695828
    [Abstract] [Full Text] [Related]

  • 26. 8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists.
    Ivachtchenko AV, Mitkin OD, Tkachenko SE, Okun IM, Kysil VM.
    Eur J Med Chem; 2010 Feb 01; 45(2):782-9. PubMed ID: 19939513
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT₂B and 5-HT₇ receptor antagonists. Part 2.
    Moritomo A, Yamada H, Watanabe T, Itahana H, Koga Y, Akuzawa S, Okada M.
    Bioorg Med Chem; 2014 Aug 01; 22(15):4323-37. PubMed ID: 24916029
    [Abstract] [Full Text] [Related]

  • 29. N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT₆ receptor antagonists.
    Nirogi RV, Konda JB, Kambhampati R, Shinde A, Bandyala TR, Gudla P, Kandukuri KK, Jayarajan P, Kandikere V, Dubey PK.
    Bioorg Med Chem Lett; 2012 Nov 15; 22(22):6980-5. PubMed ID: 23036955
    [Abstract] [Full Text] [Related]

  • 30. 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonists.
    Zhao SH, Berger J, Clark RD, Sethofer SG, Krauss NE, Brothers JM, Martin RS, Misner DL, Schwab D, Alexandrova L.
    Bioorg Med Chem Lett; 2007 Jun 15; 17(12):3504-7. PubMed ID: 17485206
    [Abstract] [Full Text] [Related]

  • 31. 2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV, Golovina ES, Kadieva MG, Koryakova AG, Mitkin OD, Tkachenko SE, Kysil VM, Okun I.
    Eur J Med Chem; 2011 Apr 15; 46(4):1189-97. PubMed ID: 21333408
    [Abstract] [Full Text] [Related]

  • 32. Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists.
    Ahmed M, Briggs MA, Bromidge SM, Buck T, Campbell L, Deeks NJ, Garner A, Gordon L, Hamprecht DW, Holland V, Johnson CN, Medhurst AD, Mitchell DJ, Moss SF, Powles J, Seal JT, Stean TO, Stemp G, Thompson M, Trail B, Upton N, Winborn K, Witty DR.
    Bioorg Med Chem Lett; 2005 Nov 01; 15(21):4867-71. PubMed ID: 16143522
    [Abstract] [Full Text] [Related]

  • 33. Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.
    Heidempergher F, Pillan A, Pinciroli V, Vaghi F, Arrigoni C, Bolis G, Caccia C, Dho L, McArthur R, Varasi M.
    J Med Chem; 1997 Oct 10; 40(21):3369-80. PubMed ID: 9341912
    [Abstract] [Full Text] [Related]

  • 34. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I, Alonso-Cires L, López-Tudanca PL, Mosquera R, Labeaga L, Innerárity A, Orjales A.
    J Med Chem; 1999 Jul 29; 42(15):2870-80. PubMed ID: 10425096
    [Abstract] [Full Text] [Related]

  • 35. Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist.
    Riemer C, Borroni E, Levet-Trafit B, Martin JR, Poli S, Porter RH, Bös M.
    J Med Chem; 2003 Mar 27; 46(7):1273-6. PubMed ID: 12646038
    [Abstract] [Full Text] [Related]

  • 36. 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
    Shireman BT, Dvorak CA, Rudolph DA, Bonaventure P, Nepomuceno D, Dvorak L, Miller KL, Lovenberg TW, Carruthers NI.
    Bioorg Med Chem Lett; 2008 Mar 15; 18(6):2103-8. PubMed ID: 18282705
    [Abstract] [Full Text] [Related]

  • 37. Novel quinazolinone derivatives as 5-HT7 receptor ligands.
    Na YH, Hong SH, Lee JH, Park WK, Baek DJ, Koh HY, Cho YS, Choo H, Pae AN.
    Bioorg Med Chem; 2008 Mar 01; 16(5):2570-8. PubMed ID: 18083580
    [Abstract] [Full Text] [Related]

  • 38. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
    Clineschmidt BV, Reiss DR, Pettibone DJ, Robinson JL.
    J Pharmacol Exp Ther; 1985 Dec 01; 235(3):696-708. PubMed ID: 2934542
    [Abstract] [Full Text] [Related]

  • 39. Design and synthesis of novel series of 5-HT6 receptor ligands having indole, a central aromatic core and 1-amino-4 methyl piperazine as a positive ionizable group.
    Hayat F, Cho S, Rhim H, Indu Viswanath AN, Pae AN, Lee JY, Choo DJ, Choo HY.
    Bioorg Med Chem; 2013 Sep 01; 21(17):5573-82. PubMed ID: 23810425
    [Abstract] [Full Text] [Related]

  • 40. Derivatives of (R)- and (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: synthesis and interactions with 5-HT1A receptors.
    Höök BB, Cortizo L, Johansson AM, Westlind-Danielsson A, Mohell N, Hacksell U.
    J Med Chem; 1996 Sep 27; 39(20):4036-43. PubMed ID: 8831769
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.